|

Allogeneic Neonatal mesenchymal stromal cells (nMSCs) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: nMSCs infusions

Pipeline

Phase 1: 1

Top Sponsors

  • Emory University1

Indications

  • Dilated Cardiomyopathy1
  • Heart Disease1

Atlanta, Georgia1 trial

A Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A) and Pediatric (1B) Patients With Dilated Cardiomyopathy (DCM)

Hughes Spalding Children's Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.